In the article titled, “Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open‐label, parallel‐group, non‐inferiority Phase III trail” published in pages 59‐70, issue 1, vol. 8 of Chronic Diseases and Translational Medicine, 1 the information of trial registration at the end of Abstract is missing. The registration information should be: This study has been registered on www.chinadrugtrials.org.cn, registered number CTR20130080.
REFERENCE
- 1. Chen, N , Xing, C , Niu, J , et al. Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: a randomized, open‐label, parallel‐group, non‐inferiority phase III trail. Chronic Dis Transl Med 2022; 8: 59‐70. 10.1002/cdt3.13 [DOI] [PMC free article] [PubMed] [Google Scholar]